Amplitude Ventures


Amplitude Ventures is a leading venture capital firm focused on creating, building, and growing breakthrough healthcare companies. With a strong foundation in healthcare innovation, Amplitude Ventures aims to bring life-changing therapies to market, improving patient lives while delivering superior value to investors. The firm leverages its deep experience and strategic partnerships to support Canadian entrepreneurs in the healthcare sector, particularly in precision medicine, where they focus on enhancing diagnostics, developing targeted therapies, and integrating AI with biology.

Amplitude Ventures

Amplitude Ventures

Espace CDPQ, 3, Place Ville-Marie Suite 12350, Montreal, QC, H3B 0E7


What We Do

A biotech venture creation studio to discover, incubate, and drive innovation, enabling the launch of leading biotechnology companies. The fellowship brings together Canada's brightest health-focused PhD candidates, post docs, and MDs to explore biotech concepts and create novel health science companies.


Geographic Focus

Investment Stage


Portfolio

Early stage company from the founders of CRISPR Therapeutics.

#Biotechnology

Revolutionizing drug design using cryo-electron microscopy to add insights of protein visualization and molecule structure for safer and more effective therapies.

#Biotechnology

Focused on developing treatments for neurodegenerative and neurodevelopmental disorders. Lead program Pridopidine is in phase 3 trials for Huntington’s disease and ALS.

#Biotechnology

Developing a computational platform using machine learning for protein stabilization and identifying novel small molecules for rare diseases.

#Biotechnology

Leveraging single cell genomics to advance precision medicines against autoimmune diseases and cancer, using a large database of patient samples and machine learning.

#Biotechnology

Utilizing AI small molecule design platform with chemistry and biology expertise to design better drugs for various diseases.

#Biotechnology


Key People